Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Faraz AliCEO | Tenaya TherapeuticsTNYA | Open-market sale | 05/18 | 05/19 | 3,390 sh | $0.79 | $2,678.1 | −0.8% |
Whittemore TingleyChief Medical Officer | Tenaya TherapeuticsTNYA | Open-market sale | 05/18 | 05/19 | 3,121 sh | $0.79 | $2,465.59 | −1.4% |
Tomohiro HigaSVP, Finance | Tenaya TherapeuticsTNYA | Open-market sale | 05/18 | 05/19 | 1,485 sh | $0.79 | $1,173.15 | −1.2% |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/24–02/25 | 02/26 | 4,170,266 sh4 trades | $0.57avg. | $2,374,855.36 | −100.0% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/20–02/23 | 02/24 | 829,734 sh4 trades | $0.61avg. | $503,077.74 | −27.3% | |
Tenaya TherapeuticsTNYA | Open-market sale | 02/17 | 02/17 | 14,862 sh3 trades | $0.64avg. | $9,511.68 | −3.2% |